# Post-marketing Surveillance of DC Bead in Patients With Hepatocellular Carcinoma

> **NCT02269995** · — · COMPLETED · sponsor: **Eisai Co., Ltd.** · enrollment: 300 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DEVICE:** E7040

## Key facts

- **NCT ID:** NCT02269995
- **Lead sponsor:** Eisai Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03-06
- **Primary completion:** 2015-05-14
- **Final completion:** 2015-12-25
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2018-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02269995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02269995, "Post-marketing Surveillance of DC Bead in Patients With Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02269995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*